ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 96

The Liver X Receptor Modulates Inflammatory Cytokines Based on Lxrα Polymorphism in Monocyte-Derived Macrophages and Patients with Systemic Lupus Erythematosus

Chang-Hee Suh1, Wook-Young Baek2, Hyoun-Ah Kim3 and Ju-Yang Jung2, 1Rheumatology, Ajou University School of Medicine, Suwon, Korea, Republic of (South), 2Ajou University School of Medicine, Suwon, Korea, Republic of (South), 3Department of Rheumatology, Ajou University School of Medicine, Suwon, Korea, Republic of (South)

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: cytokines, systemic lupus erythematosus (SLE) and toll-like receptors

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Liver X receptors (LXRs) have emerged as important regulators of inflammatory gene expression. Previously, we had reported that an LXRα gene promoter polymorphism (-1830 T>C) is associated with systemic lupus erythematosus (SLE). Therefore, we assessed cytokine expression in relation to LXRα polymorphism in monocyte-derived macrophages and peripheral blood mononuclear cells (PBMC) from patients with SLE.

Methods: Macrophages were obtained after 72 hours of culture of human monocytes supplemented with phorbol 12-myristate 13-acetate. Cells were transfected with LXRα promoter constructs. Additionally, PBMC-derived macrophages from the patients with SLE were evaluated for pro-inflammatory cytokines in relation to the genotypes of LXRα -1830 T>C.

Results: The expression of LXRα was increased in macrophages; levels of pro-inflammatory cytokines, such as IL-1β and TNF-α, were decreased with increased expression of LXRα. Production of pro-inflammatory cytokines varied depending on the expression of LXRα -1830 T>C genotype. In particular, decreased LXRα expression with increased pro-inflammatory cytokine expression was observed in monocyte-derived macrophages transfected with the TC genotype of LXRα -1830 T>C compared to those in cells transfected with the TT genotype. To verify the involvement of TLR in the expression of pro-inflammatory cytokines according to LXRα -1830 T>C genotype, various TLR agonists were treated in monocyte-derived macrophages transfected with the LXRα -1830 T>C. The levels of pro-inflammatory cytokines were further increased in TC genotype-transfected cells compared to those in TT genotype-transfected cells with treatment of TLR7 and TLR9 agonist. Pro-inflammatory cytokine levels were significantly decreased in TC genotype-transfected cells after treatment with TLR7 or TLR9 inhibitors. These results are consistent with those of an ex vivo study on PBMCs from patients with SLE with respect to the TC and TT genotypes of LXRα -1830.

Conclusion: These data suggest that expression levels of LXRα, according to LXRα -1830 T>C genotype, may contribute to the inflammatory response by induction of inflammatory cytokines in SLE.


Disclosure: C. H. Suh, None; W. Y. Baek, None; H. A. Kim, None; J. Y. Jung, None.

To cite this abstract in AMA style:

Suh CH, Baek WY, Kim HA, Jung JY. The Liver X Receptor Modulates Inflammatory Cytokines Based on Lxrα Polymorphism in Monocyte-Derived Macrophages and Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-liver-x-receptor-modulates-inflammatory-cytokines-based-on-lxr%ce%b1-polymorphism-in-monocyte-derived-macrophages-and-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-liver-x-receptor-modulates-inflammatory-cytokines-based-on-lxr%ce%b1-polymorphism-in-monocyte-derived-macrophages-and-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology